Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

August 19, 2026 Listing Department, Listing Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot C-1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai - 400 051 Mumbai - 400 001 Symbol: MAXHEALTH Scrip Code: 543220 Sub.: Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir / Madam, This is in continuation to our earlier intimation dated August 7, 2026 regarding petitions, including interlocutory petition, filed before the Hon'ble National Company Law Tribunal, Cuttack Bench by the legal representatives of BRS Capital Two Pte. Limited against Kalinga Hospital Ltd. ("KHL"), a subsidiary of the Company, the other shareholder of KHL from whom the Company acquired the majority equity stake and the Company. The matter was listed for hearing on August 19, 2026 at 11.30 am (IST). Details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. This disclosure will also be hosted on Company's website viz. www.maxhealthcare.in. Kindly take the same on record. Thanking you Yours truly, For Max Healthcare Institute Limited Dhiraj Aroraa EVP - Company Secretary and Compliance Officer Encl.: As above Annexure Details with respect to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Particulars Details 1. The details of any change in the status and The matter was heard by the Hon’ble National Company Law / or any development in relation to such Tribunal, Cuttack Bench (“NCLT”) on August 19, 2026. During the proceedings course of the hearing, the legal representatives of BRS Capital Two Pte. Limited sought an adjournment of the matter. Accordingly, the Hon’ble NCLT adjourned the hearing and posted the matter for further hearing on September 8, 2026. 2. In the case of litigation against key Not applicable management personnel or its promoter or ultimate person in control, regularly provide details of any in the status and / or any development in relation to such proceedings 3. In the event of settlement of the Not applicable proceedings, details of such settlement including - terms of the settlement, compensation/penalty paid (if any) and impact of such settlement on the financial position of the listed entity